록사두스타트 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 새로운 적응증에 대한 지속적인 연구, 의료비 지출 증가, 비주사성 빈혈 치료에 대한 수요 증가, 상환 정책 확대, 노인 인구 증가가 있습니다. 주요 동향으로는 경구 빈혈 치료제로의 이동, 대체 요법과의 경쟁 격화, 라이선스 계약 확대, 저산소 유도 인자 연구에 대한 투자 확대, 환자 중심 치료 접근법에 중점화 등이 있습니다.
만성 신장 질환(CKD)의 유병률 증가는 록사두스타트 시장의 성장을 이끌 것으로 예측됩니다. CKD의 이환율이 증가하고 있는 주된 원인은 인구의 고령화, 당뇨병이나 고혈압의 이환율 증가, 건강에 해로운 라이프스타일의 선택 등입니다. CKD와 관련된 빈혈을 관리하는 중요한 치료법이며, 적혈구 수준을 높이고 신장 기능 전체와 환자의 QOL을 향상시킵니다. 사상연구소(AIHW)는 CKD 사망률이 매년 상승하여 2021년에는 4.2%, 2022년에는 6.2% 증가한다고 보고했습니다.
아일랜드의 High-Tech Drugs Scheme과 같은 상환 제도의 확대는 환자에게 록사두스타트를 보다 이용하기 쉽게 함으로써 록사두스타트 시장 성장을 가속화하고 있습니다. 아일랜드의 정부 운영 프로그램인 '첨단 의약품 제도(High-Tech Drugs Scheme)'는 고액의 특수한 의약품을 대상으로 하며 환자의 재정적 부담을 줄이고 보다 광범위한 채택을 지원하고 있습니다. 저산소 유도 인자 프롤릴 히드록실라제(HIF-PH) 억제제로 투석 상황이나 적혈구 조혈 자극 인자(ESA) 치료의 이전에 관계없이 CKD 환자의 목표 헤모글로빈 수치( 10-12g/dL)의 달성 및 유지에 유효하다는 것이 입증되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 록사두스타트 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계 록사두스타트 시장 : 성장률 분석
- 세계 록사두스타트 시장 실적 : 규모와 성장, 2019-2024
- 세계 록사두스타트 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 록사두스타트 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 록사두스타트 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 20mg
- 50mg
- 세계의 록사두스타트 시장 : 제품 배합, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 경구정
- 세계의 록사두스타트 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 전문 약국
- 투석 센터
- 세계의 록사두스타트 시장 : 최종 사용자 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 만성 신장병 관련 빈혈
- 기타 빈혈 증상
제7장 지역별/국가별 분석
- 세계의 록사두스타트 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 록사두스타트 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 록사두스타트 시장 : 경쟁 구도
- 록사두스타트 시장 : 기업 프로파일
- AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Hetero Drugs Limited Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Akebia Therapeutics Inc.
- Metrochem API Private Limited
- FibroGen Inc.
- AMI Lifesciences
- Lee Pharma Ltd.
- Faran Shimi Pharmaceutical Company
- Maithri Drugs Pvt. Ltd.
- Clearsynth Labs Ltd.
- Bal Pharma
- HEMA Pharmaceuticals Pvt. Ltd.
- Zhejiang Hengkang Pharmaceutical Co. Ltd.
- Kimia Biosciences Pvt. Ltd.
- Lewens Labs Pvt. Ltd.
- Hangzhou Longshine Bio-Tech Co. Ltd.
- GLR Innovations
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 록사두스타트 시장 2029 : 새로운 기회를 제공하는 국가
- 록사두스타트 시장 2029 : 새로운 기회를 제공하는 부문
- 록사두스타트 시장 2029 : 성장 전략
제36장 부록
SHW
Roxadustat is an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that stabilizes hypoxia-inducible factors, promoting increased erythropoietin production, enhanced iron absorption, and improved hemoglobin synthesis without requiring exogenous erythropoiesis-stimulating agents. It is primarily used to manage anemia by addressing low hemoglobin levels in patients with chronic kidney disease and potentially other conditions involving impaired red blood cell production.
The main types of Roxadustat include 20 mg and 50 mg formulations. The 20 mg variant is an oral HIF-PHI used for treating anemia associated with chronic kidney disease by stimulating endogenous erythropoietin production. Roxadustat is available in oral tablet form and is distributed through hospitals, specialty pharmacies, and dialysis centers. It is primarily used for chronic kidney disease-associated anemia and other related conditions.
The Roxadustat market research report is one of a series of new reports from The Business Research Company that provides Roxadustat market statistics, including Roxadustat industry global market size, regional shares, competitors with a Roxadustat market share, detailed Roxadustat market segments, market trends and opportunities, and any further data you may need to thrive in the Roxadustat industry. This Roxadustat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The Roxadustat market size has grown strongly in recent years. It will grow from $6.44 billion in 2024 to $6.92 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to regulatory approvals in major markets, strong clinical trial results, the increasing prevalence of chronic kidney disease, rising awareness of anemia management, and government support for anemia treatments.
The Roxadustat market size is expected to see strong growth in the next few years. It will grow to $9.16 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to ongoing research for new indications, increasing healthcare expenditure, rising demand for non-injectable anemia treatments, expanding reimbursement policies, and a growing geriatric population. Major trends include a shift toward oral anemia treatments, increasing competition from alternative therapies, the expansion of licensing agreements, growing investment in hypoxia-inducible factor research, and a stronger focus on patient-centric treatment approaches.
The rising prevalence of chronic kidney disease (CKD) is expected to drive the growth of the Roxadustat market. CKD is a progressive condition where kidney function deteriorates over time, often leading to kidney failure if not properly managed. The increasing incidence of CKD is primarily due to aging populations, higher rates of diabetes and hypertension, and unhealthy lifestyle choices. Roxadustat is a key treatment for managing CKD-related anemia by stimulating erythropoietin production, which boosts red blood cell levels and enhances overall kidney function and patient quality of life. For instance, in December 2024, the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, reported an annual rise in CKD mortality rates, with increases of 4.2% in 2021 and 6.2% in 2022. As a result, the growing number of CKD cases is fueling the demand for Roxadustat.
The expansion of reimbursement programs, such as Ireland's High-Tech Drugs Scheme, is accelerating Roxadustat's market growth by making it more accessible to patients. The High-Tech Drugs Scheme, a government-managed program in Ireland, covers high-cost, specialized medications, reducing financial barriers for patients and supporting broader adoption. For example, in September 2022, Astellas Pharma Company Ltd., a US-based pharmaceutical company, announced that EVRENZO (Roxadustat) received reimbursement under Ireland's High-Tech Drugs Scheme. Roxadustat, the first orally administered hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor approved in Ireland, demonstrated effectiveness in achieving and maintaining target hemoglobin levels (10-12g/dL) in CKD patients, regardless of their dialysis status or previous erythropoiesis-stimulating agent (ESA) treatment. Such reimbursement initiatives are expected to enhance patient access and drive market expansion.
In February 2024, FibroGen Inc., a US-based biopharmaceutical company, partnered with Astellas Pharma Inc. and AstraZeneca PLC to further develop and distribute Roxadustat for anemia associated with CKD and other conditions, such as myelodysplastic syndromes (MDS). Astellas Pharma, a Japan-based pharmaceutical company, and AstraZeneca, a UK-based pharmaceutical giant, bring extensive expertise in global commercialization, further boosting Roxadustat's market potential. These partnerships highlight the growing investment and focus on expanding treatment options for CKD-related anemia, solidifying Roxadustat's position in the market.
Major players in the Roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.
North America was the largest region in the Roxadustat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in Roxadustat report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Roxadustat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The Roxadustat market consists of sales of products such as 70 mg, 100 mg, and 150 mg film-coated tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Roxadustat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on roxadustat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for roxadustat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The roxadustat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: 20mg; 50mg
- 2) By Product Formulation: Oral Tablets
- 3) By Distribution Channel: Hospitals; Specialty Pharmacies; Dialysis Centers
- 4) By End-User Application: Chronic Kidney Disease-Associated Anemia; Other Anemia Conditions
- Companies Mentioned: AstraZeneca PLC; Viatris Inc.; Astellas Pharma Inc.; Dr. Reddy's Laboratories Ltd.; Hetero Drugs Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Roxadustat Market Characteristics
3. Roxadustat Market Trends And Strategies
4. Roxadustat Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Roxadustat Growth Analysis And Strategic Analysis Framework
- 5.1. Global Roxadustat PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Roxadustat Market Growth Rate Analysis
- 5.4. Global Roxadustat Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Roxadustat Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Roxadustat Total Addressable Market (TAM)
6. Roxadustat Market Segmentation
- 6.1. Global Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20mg
- 50mg
- 6.2. Global Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Tablets
- 6.3. Global Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Pharmacies
- Dialysis Centers
- 6.4. Global Roxadustat Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chronic Kidney Disease-Associated Anemia
- Other Anemia Conditions
7. Roxadustat Market Regional And Country Analysis
- 7.1. Global Roxadustat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Roxadustat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Roxadustat Market
- 8.1. Asia-Pacific Roxadustat Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Roxadustat Market
- 9.1. China Roxadustat Market Overview
- 9.2. China Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Roxadustat Market
- 10.1. India Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Roxadustat Market
- 11.1. Japan Roxadustat Market Overview
- 11.2. Japan Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Roxadustat Market
- 12.1. Australia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Roxadustat Market
- 13.1. Indonesia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Roxadustat Market
- 14.1. South Korea Roxadustat Market Overview
- 14.2. South Korea Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Roxadustat Market
- 15.1. Western Europe Roxadustat Market Overview
- 15.2. Western Europe Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Roxadustat Market
- 16.1. UK Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Roxadustat Market
- 17.1. Germany Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Roxadustat Market
- 18.1. France Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Roxadustat Market
- 19.1. Italy Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Roxadustat Market
- 20.1. Spain Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Roxadustat Market
- 21.1. Eastern Europe Roxadustat Market Overview
- 21.2. Eastern Europe Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Roxadustat Market
- 22.1. Russia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Roxadustat Market
- 23.1. North America Roxadustat Market Overview
- 23.2. North America Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Roxadustat Market
- 24.1. USA Roxadustat Market Overview
- 24.2. USA Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Roxadustat Market
- 25.1. Canada Roxadustat Market Overview
- 25.2. Canada Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Roxadustat Market
- 26.1. South America Roxadustat Market Overview
- 26.2. South America Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Roxadustat Market
- 27.1. Brazil Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Roxadustat Market
- 28.1. Middle East Roxadustat Market Overview
- 28.2. Middle East Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Roxadustat Market
- 29.1. Africa Roxadustat Market Overview
- 29.2. Africa Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Roxadustat Market Competitive Landscape And Company Profiles
- 30.1. Roxadustat Market Competitive Landscape
- 30.2. Roxadustat Market Company Profiles
- 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hetero Drugs Limited Overview, Products and Services, Strategy and Financial Analysis
31. Roxadustat Market Other Major And Innovative Companies
- 31.1. Akebia Therapeutics Inc.
- 31.2. Metrochem API Private Limited
- 31.3. FibroGen Inc.
- 31.4. AMI Lifesciences
- 31.5. Lee Pharma Ltd.
- 31.6. Faran Shimi Pharmaceutical Company
- 31.7. Maithri Drugs Pvt. Ltd.
- 31.8. Clearsynth Labs Ltd.
- 31.9. Bal Pharma
- 31.10. HEMA Pharmaceuticals Pvt. Ltd.
- 31.11. Zhejiang Hengkang Pharmaceutical Co. Ltd.
- 31.12. Kimia Biosciences Pvt. Ltd.
- 31.13. Lewens Labs Pvt. Ltd.
- 31.14. Hangzhou Longshine Bio-Tech Co. Ltd.
- 31.15. GLR Innovations
32. Global Roxadustat Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Roxadustat Market
34. Recent Developments In The Roxadustat Market
35. Roxadustat Market High Potential Countries, Segments and Strategies
- 35.1 Roxadustat Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Roxadustat Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Roxadustat Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
